This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., The Medicines Company. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2023
Title: The Innovative Contributions of Jayne Prats
Introduction
Jayne Prats is a notable inventor based in Carlisle, MA (US), recognized for her significant contributions to the field of pharmaceuticals. With a total of 12 patents to her name, she has made remarkable advancements in methods for treating ischemic events, particularly in patients undergoing percutaneous coronary intervention (PCI).
Latest Patents
Among her latest patents, Prats has developed methods for treating, reducing the incidence of, and preventing ischemic events. One of her key inventions involves administering a pharmaceutical composition comprising cangrelor to patients undergoing PCI. This method may also include administering an additional therapeutic agent, such as bivalirudin or a P2Y inhibitor. Furthermore, she has created pharmaceutical compositions that are effective in treating ischemic events, which may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality. Another significant patent focuses on maintaining platelet inhibition during antiplatelet therapy, where cangrelor is administered prior to invasive procedures to reduce the risk of thrombosis without increasing the risk of excessive bleeding.
Career Highlights
Throughout her career, Jayne Prats has worked with prominent companies in the pharmaceutical industry, including Chiesi Farmaceutici S.p.a. and The Medicines Company. Her work has been instrumental in advancing treatments that improve patient outcomes in cardiovascular health.
Collaborations
Prats has collaborated with talented professionals in her field, including Simona Skerjanec and Lisa Ruderman Chen. These collaborations have contributed to her innovative research and development efforts.
Conclusion
Jayne Prats exemplifies the spirit of innovation in the pharmaceutical industry, with her groundbreaking patents and collaborations paving the way for improved treatments for ischemic events. Her work continues to impact the lives of patients undergoing critical medical procedures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile